Clinical applications of therapeutic phlebotomy [PDF]
Journal of Blood Medicine, 2016 Kyung Hee Kim,1 Ki Young Oh,2 1Department of Laboratory Medicine, Gachon University Gil Medical Center, Incheon, 2Department of Physical Medicine and Rehabilitation, Soonchunhyang University, Cheonan Hospital, Cheonan, South Korea Abstract: Phlebotomy is
Kim KH, Oh KY
doaj +9 more sources
NTBI levels in C282Y homozygotes after therapeutic phlebotomy [PDF]
eJHaem, 2022 C282Y homozygotes exposed to sustained elevated transferrin saturation (TS) may develop worsening clinical symptoms. This might be related to the appearance of non‐transferrin bound iron (NTBI) when TS≥50% and labile plasma iron (LPI) when TS levels ...
Eleanor Ryan +5 more
doaj +7 more sources
Hydralazine Associated With Reduced Therapeutic Phlebotomy Frequency in a Nationwide Cohort Study: Real-World Effectiveness for Drug Repurposing [PDF]
Frontiers in Pharmacology, 2022 Background: Therapeutic phlebotomy, known as scheduled bloodletting, has been the main method for managing erythrocytosis symptoms and thrombocytosis-associated complications in various blood disorders.
Wei-Zhi Lin +11 more
doaj +6 more sources
Unexplained Hematocrit Increase after Therapeutic Phlebotomy in a Patient with Marked Erythrocytosis [PDF]
Case Reports in Hematology, 2022 We report a patient with hereditary erythrocytosis who underwent a therapeutic phlebotomy and had a post-phlebotomy hematocrit that was higher than the pre-phlebotomy hematocrit. We could not discern a reason for this hematocrit increase after phlebotomy.
Rushad Machhi +5 more
doaj +7 more sources
Indications and use of therapeutic phlebotomy in polycythemia vera: which role for erythrocytapheresis? [PDF]
Leukemia, 2019 The Italian Societies of Hematology and Blood Transfusion issued recent recommendations for phlebotomy in polycythemia vera (PV), to obtain a target hematocrit <45%
Teofili L +3 more
europepmc +4 more sources
Effect of therapeutic phlebotomy on plasma volume in polycythemia patients
Global Journal of Transfusion Medicine, 2018 Background: Therapeutic phlebotomy (TP) helps in reducing the red cell mass thereby whole blood viscosity to improve tissue perfusion and oxygen delivery in polycythemia patients.
Mohandoss Murugesan +2 more
doaj +3 more sources
Nine treatments of 1000 mL therapeutic phlebotomy in a subject with polycythemia: A case report [PDF]
Physiological ReportsLarge‐volume therapeutic phlebotomy is the mainstay of hemochromatosis treatment and offers an opportunity to investigate the hemodynamic changes during acute hypovolemia. An otherwise healthy 64‐year‐old male with hemochromatosis participated.
William J. Morton +5 more
doaj +4 more sources
PB2505: THERAPEUTIC PHLEBOTOMY INSTANTLY AFFECTS BLOOD PARAMETERS AND VISCOCITY IN SICKLE CELL DISEASE PATIENTS [PDF]
HemaSphere, 2023 Amna Jebali +5 more
doaj +3 more sources
Role of therapeutic apheresis and phlebotomy techniques in anaesthesia and critical care
Indian Journal of Anaesthesia, 2014 Therapeutic transfusion techniques such as apheresis and phlebotomy are frequently used in intensive care units. Use of the apheresis technique for the treatment of various diseases in critically ill patients is growing day by day. There are increasing evidences for using apheresis as a primary therapy or as an adjunct to other therapies for various ...
Neeta Bose, Hitendra Kanzariya
doaj +4 more sources